
Coherence Neuro
Investigational neurotechnology for monitoring and treating cancer from inside the body
- Soha
- MedTech
- Tashkil etilgan
- 2022
- Joylashuv
- United Kingdom
Tasdiqlangan daromad: hali ulanmagan
Coherence Neuro sizningmi? Ushbu sahifani soʻrang va Stripe, App Store yoki Google Play’ni ulang: MRR va oʻsishingiz shu yerda toʻgʻridan-toʻgʻri manbadan koʻrinadi.
Startap haqida
Coherence Neuro is developing neurotechnology, including the CIPHER System and the SOMA brain-computer interface, to monitor cancer and deliver therapeutic stimulation. Its devices are investigational and not approved by the FDA or TGA; a first-in-human study started in Melbourne in 2026. It is based in San Francisco and backed by Armenia-based SmartGate VC.
Jamoa
- Ben Woodington, Co-founder and CEO (Asoschi)
- Elise Jenkins, Co-founder and CTO (Asoschi)
Auditoriya
Ijtimoiy tarmoqlardagi kuzatuvchilar
Profil maʼlumotlari manbasi: Stanbase.